Breaking News

Sartorius Launches Automated Bioreactor System

The ambr® 250 high throughput (ht) perfusion is an automated parallel bioreactor system for rapid cell culture perfusion

Sartorius Stedim Biotech announced the launch of the ambr® 250 high throughput (ht) perfusion, a new automated parallel bioreactor system.    It has been specially designed for rapid cell culture perfusion process development to optimize production of therapeutic antibodies. The system will be launched at the BPI West 2018 Conference in San Francisco, USA    The ambr 250ht perfusion system has been developed in collaboration with major biopharma companies. It combines 12 or 24 si...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters